A new strategic focus from specialty pharma company Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart, News TSX:CPH) raises a number … [Read more...] about Take a pass on Cipher Pharmaceuticals, says GMP Securities
Life Sciences
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Medical Facilities Corporation has target slashed at Echelon Wealth
A sharp drop in its dividend is cause for a target price reduction on Medical Facilities Corporation (Medical Facilities Corporation Stock Quote, … [Read more...] about Medical Facilities Corporation has target slashed at Echelon Wealth
Profound Medical gets news $45.00 target at Paradigm
Paradigm Capital analyst Corey Hammill likes the long-term forecast for medical device company Profound Medical (Profound Medical Stock Quote, Chart, … [Read more...] about Profound Medical gets news $45.00 target at Paradigm
2020 could be a breakout year for Tetra Bio-Pharma, says Paradigm Capital
Cannabis biopharmaceutical company Tetra Bio-Pharma (Tetra Bio-Pharma Stock Quote, Chart, News TSXV:TBP) is setting up for a big year in 2020, … [Read more...] about 2020 could be a breakout year for Tetra Bio-Pharma, says Paradigm Capital
Medicenna is “highly undervalued”, says Mackie Research
Mackie Research analyst André Uddin maintains that oncology-focused immunotherapy company Medicenna (Medicenna Stock Quote, Chart, News TSX:MDNA) … [Read more...] about Medicenna is “highly undervalued”, says Mackie Research
Paradigm Capital launches coverage of Spectral Medical with a “Buy”
Microcap Spectral Medical (Spectral Medical Stock Quote, Chart, News TSX:EDT) got the spotlight in a coverage initiation by Paradigm Capital on … [Read more...] about Paradigm Capital launches coverage of Spectral Medical with a “Buy”
Aurinia Pharmaceuticals is a biopharma stock you should own, Mackie says
All eyes are on Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, Chart, News NASDAQ:AUPH), which just announced the start of a patient … [Read more...] about Aurinia Pharmaceuticals is a biopharma stock you should own, Mackie says
Knight Therapeutics upgraded to “Buy” at Mackie Research
Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) is still in the early innings of its growth trajectory, says Mackie … [Read more...] about Knight Therapeutics upgraded to “Buy” at Mackie Research
Burcon NutraScience is still undervalued, Beacon says
With more fast food chains jumping on the plant protein bandwagon, Beacon Securities analyst Spencer Churchill is liking the opportunity landscape for … [Read more...] about Burcon NutraScience is still undervalued, Beacon says
Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP
The massive new acquisition of Grupo Biotoscana by Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) is a huge positive, says GMP … [Read more...] about Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP
